FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

416375002: Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3762275019 Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3762276018 Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator unit Milliliter (qualifier value) true Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Count of base of active ingredient deux false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator unit Milliliter (qualifier value) true Inferred relationship Some 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator value un false Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength denominator value un false Inferred relationship Some 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension est un(e) (attribut) Loteprednol and tobramycin only product in ocular dose form true Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has precise active ingredient Loteprednol etabonate (substance) true Inferred relationship Some 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has precise active ingredient Tobramycin (substance) true Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has basis of strength substance (attribute) Tobramycin (substance) true Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator value (attribute) cinq false Inferred relationship Some 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator value (attribute) trois false Inferred relationship Some 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has basis of strength substance (attribute) Loteprednol etabonate (substance) true Inferred relationship Some 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Plays role Antibacterial therapeutic role (role) true Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension est un(e) (attribut) Loteprednol etabonate + tobramycin (product) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a pour principe actif (attribut) Corticosterone false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a pour principe actif (attribut) Adrenal hormone agent (substance) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a pour principe actif (attribut) Tobramycin (substance) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a pour principe actif (attribut) Loteprednol etabonate (substance) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a pour principe actif (attribut) Glucocorticoid hormone false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a pour principe actif (attribut) Bactericide false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a une forme pharmaceutique (attribut) forme pharmaceutique pour usage oculaire (forme pharmaceutique) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension est un(e) (attribut) Loteprednol etabonate ophthalmic preparation (product) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension est un(e) (attribut) Product containing tobramycin in ophthalmic dosage form (medicinal product form) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension a une forme pharmaceutique (attribut) Eye suspension true Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension est un(e) (attribut) Product containing loteprednol and tobramycin (medicinal product) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension est un(e) (attribut) Product containing loteprednol in ocular dose form (medicinal product form) false Inferred relationship Some
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension est un(e) (attribut) TEMPORARY parent for CDs that are not updated false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start